The goal of RealWorld4Clinic is to develop MyHeartSentinel, an AI-powered health monitoring solution, which can be applied both in clinical research and in cardiological patient care. This new device will continuously measure a wide array of cardio-respiratory health parameters in clinical trial volunteers and patients in their normal everyday environment.
The data that this device will provide will be passed on to healthcare personnel and allow insights into important biomarkers almost in real-time. This could be lifesaving for many patients that suffer from heart failure. The data will help detect early warning signs of an upcoming heart failure decompensation up to 30 days before the catastrophic event occurs, ensuring that preventative measures can be taken well in advance in the vast majority of cases.
RealWorld4Clinic could halve the rate of emergency hospitalisation and significantly reduce the number of ambulatory visits. In addition, data collected by the device could strongly support early decision making in clinical development programs and improve the predictive power of clinical trials by up to 50%.
Real-World Cardio-Respiratory Health Monitoring for Clinical Contract Research and Tele-Cardiology
1 January 2020 - 31 December 2022 (36 Months)
Profil Institut für Stoffwechselforschung GmbH